Immatics (IMTX) Receivables (2019 - 2025)
Immatics' (IMTX) quarterly Receivables came in at $7.1 million in Q4 2025, up 12.61% year-on-year from $6.3 million in Q4 2024, and up 89.84% quarter-over-quarter from $3.7 million in Q3 2025.
Immatics (IMTX) Receivables (2019 - 2025) Analysis & Trends
Immatics has disclosed Receivables across 7 years of filings, most recently posting $7.1 million for Q4 2025.
- Receivables for Q4 2025 came in at $7.1 million, up 12.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.1 million (up 12.61% YoY), and the FY2025 annual result was $6.9 million, up 9.29% from the prior year.
- Receivables came in at $7.1 million for Q4 2025 at Immatics, up from $3.7 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $7.1 million in Q4 2025 to a low of $247942.0 in Q1 2023.
- The 5-year median for Receivables is $1.1 million (2022), against an average of $2.3 million.
- Across the five-year window, Receivables tumbled 70.23% in 2023 and soared 742.4% in 2024, its largest moves.
- Immatics' Receivables stood at $800779.7 in 2021, then soared by 41.55% to $1.1 million in 2022, then surged by 288.52% to $4.4 million in 2023, then jumped by 43.16% to $6.3 million in 2024, then increased by 12.61% to $7.1 million in 2025.
- The last three Receivables figures came in at $7.1 million (Q4 2025), $3.7 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 13.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.00 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 7.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.10 Mn |
| Sep 30, 2025 | 3.74 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 5.89 Mn |
| Dec 31, 2024 | 6.30 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.03 Mn |
| Mar 31, 2024 | 1.93 Mn |
| Dec 31, 2023 | 4.40 Mn |
| Sep 30, 2023 | 559,535.51 |
| Jun 30, 2023 | 359,345.05 |
| Mar 31, 2023 | 247,941.96 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.15 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 832,774.59 |
| Dec 31, 2021 | 800,779.67 |
| Sep 30, 2021 | 854,983.31 |
| Jun 30, 2021 | 864,666.89 |
| Mar 31, 2021 | 693,585.76 |